{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:45:19Z","timestamp":1774475119443,"version":"3.50.1"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T00:00:00Z","timestamp":1353456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0050366","type":"journal-article","created":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T23:03:19Z","timestamp":1353538999000},"page":"e50366","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":162,"title":["Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing"],"prefix":"10.1371","volume":"7","author":[{"given":"Hatem A.","family":"Elshabrawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa M.","family":"Coughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan C.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bellur S.","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,11,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"JS Peiris","year":"2004","journal-title":"Nat Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virol.2005.01.034","article-title":"Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines","volume":"334","author":"Y He","year":"2005","journal-title":"Virology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1371\/journal.pone.0000024","article-title":"Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus","volume":"1","author":"T Li","year":"2006","journal-title":"PLoS One"},{"key":"ref4","first-page":"119","article-title":"Immunological responses against SARS-coronavirus infection in humans","volume":"1","author":"X Xu","year":"2004","journal-title":"Cell Mol Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"ZY Yang","year":"2004","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.1087139","article-title":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China","volume":"302","author":"Y Guan","year":"2003","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"11892","DOI":"10.1128\/JVI.79.18.11892-11900.2005","article-title":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms","volume":"79","author":"B Kan","year":"2005","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1073\/pnas.0506735102","article-title":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats","volume":"102","author":"SK Lau","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"W Li","year":"2005","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"JS Peiris","year":"2003","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virol.2009.07.028","article-title":"Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms","volume":"394","author":"MM Coughlin","year":"2009","journal-title":"Virology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1128\/JVI.02377-07","article-title":"Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge","volume":"82","author":"B Rockx","year":"2008","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1086\/651022","article-title":"Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus","volume":"201","author":"B Rockx","year":"2010","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"SK Wong","year":"2004","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"20836","DOI":"10.1074\/jbc.M400759200","article-title":"Structural characterization of the SARS-coronavirus spike S fusion protein core","volume":"279","author":"B Tripet","year":"2004","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2013a target for vaccine and therapeutic development","volume":"7","author":"L Du","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1085953","article-title":"The Genome sequence of the SARS-associated coronavirus","volume":"300","author":"MA Marra","year":"2003","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"F Li","year":"2005","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.virol.2006.09.029","article-title":"Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse","volume":"361","author":"M Coughlin","year":"2007","journal-title":"Virology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.174.8.4908","article-title":"Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies","volume":"174","author":"Y He","year":"2005","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.1073\/pnas.0402753101","article-title":"Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus","volume":"101","author":"P Ingallinella","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1128\/JVI.00415-08","article-title":"Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide","volume":"82","author":"BJ Bosch","year":"2008","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1074\/jbc.M508381200","article-title":"SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells","volume":"281","author":"IC Huang","year":"2006","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1128\/JVI.79.11.7195-7206.2005","article-title":"Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein","volume":"79","author":"B Sainz Jr","year":"2005","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2008.10.001","article-title":"Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors","volume":"81","author":"IJ Liu","year":"2009","journal-title":"Antiviral Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/JVI.80.2.941-950.2006","article-title":"Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus","volume":"80","author":"KM Lip","year":"2006","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11373-005-9004-3","article-title":"Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)","volume":"12","author":"SC Lai","year":"2005","journal-title":"J Biomed Sci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1743-422X-2-73","article-title":"The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization","volume":"2","author":"S Chakraborti","year":"2005","journal-title":"Virol J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1128\/JVI.78.13.6938-6945.2004","article-title":"Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies","volume":"78","author":"H Zhang","year":"2004","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1128\/JVI.79.6.3289-3296.2005","article-title":"Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents","volume":"79","author":"CT Keng","year":"2005","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1476-4598-9-299","article-title":"Luciferase expression and bioluminescence does not affect tumor cell growth in vitro or in vivo","volume":"9","author":"JC Tiffen","year":"2010","journal-title":"Mol Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1128\/JVI.01394-09","article-title":"Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission","volume":"84","author":"RL Graham","year":"2010","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1073\/pnas.0409608102","article-title":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human","volume":"102","author":"HD Song","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1128\/JVI.79.6.3401-3408.2005","article-title":"B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein","volume":"79","author":"X Zhong","year":"2005","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/JVI.80.2.941-950.2006","article-title":"Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus","volume":"80","author":"KM Lip","year":"2006","journal-title":"Journal of Virology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","article-title":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants","volume":"3","author":"J ter Meulen","year":"2006","journal-title":"PLoS Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nbt1363","article-title":"The growth and potential of human antiviral monoclonal antibody therapeutics","volume":"25","author":"WA Marasco","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e5672","DOI":"10.1371\/journal.pone.0005672","article-title":"Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants","volume":"4","author":"M Prabakaran","year":"2009","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00002030-198912000-00001","article-title":"Characterization of HIV-1 neutralization escape mutants","volume":"3","author":"JA McKeating","year":"1989","journal-title":"AIDS"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants","volume":"79","author":"AB Bakker","year":"2005","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1089\/hyb.2005.24.36","article-title":"Preparation and characterization of monoclonal antibodies against nucleostemin, a protein that controls cell proliferation in stem cells and cancer cells","volume":"24","author":"H Yang","year":"2005","journal-title":"Hybridoma (Larchmt)"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0092-8674(00)81710-9","article-title":"Coiled coils in both intracellular vesicle and viral membrane fusion","volume":"95","author":"JJ Skehel","year":"1998","journal-title":"Cell"},{"key":"ref43","unstructured":"McLellan JS, Pancera M, Carrico C, Gorman J, Julien JP, <etal>et al<\/etal>. (2011) Structure of HIV-1 gp120 V1\/V2 domain with broadly neutralizing antibody PG9. Nature."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0050366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T21:38:04Z","timestamp":1562362684000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0050366"}},"subtitle":[],"editor":[{"given":"Krzysztof","family":"Pyrc","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,21]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0050366","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,21]]}}}